Alliance for mRNA Medicines
Join Us
amm ascent

meeting agenda

Agenda

7:30 AM – 9:30 AM

Breakfast

8:30 AM – 10:00 AM

AMM Board Meeting (Board Members Only)

10:00 AM – 5:00 PM

Partnering and Exhibits Open

10:30 AM – 10:40 AM

Conference Opening and Welcome

10:40 AM – 11:30 AM

Global Industry Outlook for mRNA

11:30 AM – 12:30 PM

Fireside Chat: What’s Next After Baby KJ? The Future of mRNA in Gene Editing and Rare Disease

  • Moderator: Sadik Kassim, Chief Scientific Officer & Chief Technology Officer, Danaher Corporation
  • Rob Leone, Sr. Director, Chemistry, Marnufacturing & Controls, Acuitas Therapeutics
  • Fyodor Urnov, Director of Technology and Translations, Innovative Genomics Institute

12:30 PM – 1:20 PM

Lunch

1:20 PM – 2:25 PM

Presentation and Discussion Session: Innovation in mRNA and Cancer Immunotherapies

  • Moderator: Andreas Kuhn, SVP Biochemistry and Manufacturing, BioNTech
  • Gad Berdugo, Chief Business Officer, Nutcracker Therapeutics
  • Gilles Besin, Chief Science Officer, Orbital Therapeutics 
  • John Cooke, Chief Translational Sciences Officer & Medical Director for RNA Therapeutics, Houston Methodist  

2:25 PM – 2:35 PM

Break

2:35 PM – 3:15 PM

Global Regulatory Outlook for mRNA Products

  • Moderators: Ye Zhang, Chief Regulatory Officer, Arcturus Therapeutics and David Schmickel, Director, Global Regulatory Science, Policy and Intelligence, CSL Behring
  • Peter Marks, former Director, Center for Biologics Evaluation and Research, US Food and Drug Administration (virtual) 
  • Julie Tierney, Principal, Leavitt Partners and former Deputy Director, FDA Center for Biologics Evaluation and Research 

3:15 PM – 4:00 PM

Large Cap/Biopharm’s Role in mRNA Commercialization

4:00 PM – 4:15 PM

Break

4:15 PM – 5:00 PM

Meeting the Moment in mRNA

5:00 PM – 6:00 PM

Break

6:00 PM – 8:30 PM

Opening Reception 

7:30 AM – 9:00 AM

Breakfast

9:00 AM – 5:00 PM

Partnering and Exhibits Open

9:00 AM – 10:00 AM

Turning Research to Reality: Translational Projects from Academia

  • Phil Felgner, Professor in Residence, Physiology and Biophysics, UC Irvine School of Medicine 
  • Andrew Varley, Director, RNA and Formulation Core, University of British Columbia 
  • Gene Yeo, Professor of Cellular and Molecular Medicine, University of California San Diego 

10:00 AM – 10:45 AM

Panel Discussion and Presentations

Moderator, Jeff Coller, Bloomberg Distinguished Professor of RNA Biology and Therapeutics, Johns Hopkins University 

10:45 AM – 11:15 AM

Break

11:15 AM – 12:00 PM

Three 15-Minute Company Presentations

  • Nathaniel Wang, CEO, Replicate Bioscience 
  • Helge Zieler, PhD, CEO of Primrose Bio 
  • Marek Baranowski, Co-founder and Director of Research and Quality Development, ExploRNA

12:00 PM – 1:30 PM

Lunch and Networking

1:30 PM – 2:30 PM

Future of AI in mRNA Development

2:30 PM – 3:30 PM

Four 15-min Company Presentations

  • Eduardo Velasquez, Senior Director, Research and Economic Development, San Diego Economic Development Corporation 

3:30 PM – 3:45 PM

Break

3:45 PM – 4:30 PM

mRNA Manufacturing, CMC, and Analytics

4:30 PM – 5:00 PM

Break

5:00 PM – 7:00 PM

Reception (Bayside Lawn)

7:30 AM – 9:00 AM

Breakfast

9:00 AM – 9:15 AM

One 15-Minute Company Presentations
  • Dan Mallon, SVP Corporate Development, PharmaJet  

9:15 AM – 10:00 AM

mRNA Therapeutics: Understanding the Global Market

10:00 AM – 10:45 AM

mRNA Delivery Innovation

10:45 AM - 11:00 AM

Break

11:00 AM – 11:45 PM

Our mRNA Future

11:45 AM – 12:00 PM

Closing Remarks